Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

PROMUS Elementâ„¢ Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study

May 20, 2011 1:42 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass. and PARIS, May 20, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced 12-month results from its PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Element™ Everolimus-Eluting Platinum Chromium...

A Nanotubes Patch to Help Heal the Heart

May 19, 2011 2:35 pm | by Massachusetts Institute of Technology | News | Comments

Researchers create carbon nanotubes that mimic natural tissue and can regenerate heart cells in a dish.

Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise

May 19, 2011 10:43 am | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill., May 19, 2011 /- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Reisenauer will be responsible for all U.S....

Advertisement

Spaulding Clinical Honored at BizTech Conference

May 19, 2011 8:39 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., May 19, 2011 /- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly receives the 2011 IQ (Innovation Quotient) award sponsored by the Marquette University's Graduate School of Management and BizTimes Media, a magazine...

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist

May 19, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA, May 19, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D. , is a finalist for the...

Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay

May 18, 2011 11:46 am | by Bio-Medicine.Org | News | Comments

BERLIN, May 18, 2011 /- Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary...

FluoroPharma Announces Completion of Merger and Fund Raising

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 18, 2011 /- FluoroPharma Medical (OTC.BB: CEWM) announced that it has completed a merger transaction with Commercial E Waste Management (CEWM). Effective as of the closing of the transaction, FluoroPharma became a wholly-owned subsidiary of CEWM. The newly combined, publicly...

PLC Medical Systems Adds Vice President of Clinical Affairs

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it has named Susan Papalia, RN, BSN, Vice President of Clinical Affairs.  In her new role, she will be responsible for overseeing and...

Advertisement

CryoLife Announces Completion of Acquisition of Cardiogenesis

May 17, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, and IRVINE, Calif., May 17, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation ("Cardiogenesis"). The...

New CE Marked Prognostic Claim for the VerifyNow P2Y12 Test

May 16, 2011 11:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 17, 2011 /- Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use...

BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions

May 16, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, May 16, 2011 /- BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have received clearance of an expanded indication for the CrossBoss™ Catheter and Stingray™ System from the FDA.  The expanded indication includes the...

Abaxis Receives Presidential "E" Award for Exports

May 16, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., May 16, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company was awarded the Presidential "E" Award for Exports by U.S. Department of Commerce Secretary Gary Locke at the...

Lilly USA, LLC Launches TruAssist for Patients

May 16, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, May 16, 2011 /- Lilly USA has launched www.LillyTruAssist.com and 1-855-LLYTRUE (1-855-559-8783), a website and call center for health care providers and patients to access information about Lilly's patient assistance programs, which help connect patients with the Lilly...

Advertisement

Sensing Brain Pressure without Surgery

May 15, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A noninvasive technique could monitor concussions, migraines, and other conditions.

InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India

May 12, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

TEL AVIV, Israel, May 12, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard ™ mesh protective stent system, is happy to announce that MGuard is now available in India. MGuard, InspireMD's flagship product is India's first mesh-based...

PLC to Demonstrate RenalGuard® at EuroPCR 2011

May 12, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 12, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced it will demonstrate its innovative new product, RenalGuard®, at EuroPCR, the annual meeting of the European Association of Percutaneous...

Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke

May 11, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

RAYNHAM, Mass., May 11, 2011 /- Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE™ SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in...

Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes

May 11, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

WEST CHESTER, Pa., May 11, 2011 /- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for...

Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation

May 11, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., May 11, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that a jury in the District Court for the District of Delaware found that Cordis Corporation owed Boston Scientific approximately $19.5 million for infringing its Jang patent, which covers...

Pierrel Research USA Launches Orablocâ„¢ a New Purer Articaine

May 10, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., May 10, 2011 /- Pierrel Research USA, Inc. ( www.pierrel-research-usa.com ), a subsidiary of Pierrel SpA, the Italian-based, global pharmaceutical services company ( www.pierrel.it ), announces the US launch of Orabloc™ (Articaine hydrochloride 4% with epinephrine...

Amarin Reports First Quarter 2011 Results

May 10, 2011 12:32 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., May 10, 2011 /- Amarin Corporation plc (NASDAQ: AMRN ), a clinical-stage biopharmaceutical company focused on cardiovascular disease, today reported financial results for the quarter ended March 31, 2011 (Q1 2011). The Company also provided an update on its...

The Human Body, Searchable in 3-D

May 9, 2011 8:34 pm | by Massachusetts Institute of Technology | News | Comments

A new tool lets people see the inside of the body up close and in great detail.

Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICIDâ„¢ Phase 3 Data

May 9, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

CHICAGO, May 9, 2011 /- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced the presentation of two abstracts at the 2011 Digestive Disease Week (DDW) conference highlighting additional analyses of data from Phase 3 trials of DIFICID™ (fidaxomicin), an investigational...

Simcere Announces Recent Progress of Qiangke's Registration

May 9, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

NANJING, China, May 9, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that...

Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results

May 9, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 9, 2011 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2011.  For the three months ended March 31, 2011, Orexigen reported a net loss of...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading